Special Article
Evidence in immunotherapy for paediatric respiratory allergy: Advances and recommendations. Document of the Immunotherapy Working Group of the Spanish Society of Pediatric Clinical Immunology and Allergology (SEICAP)
M. Tortajada-Girbésa,b,
, M. Mesa del Castilloc, H. Larramonad, J.M. Lucase, M. Álvarof, A.I. Tabarg, M.J. Jerezh, A. Martínez-Cañavatei,**
Corresponding author
a Paediatric Allergology and Pulmonology Unit, Dr. Peset University Hospital, Valencia, Spain
b Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain
c Paediatric Allergology and Neumology Unit, Hospital El Escorial, Madrid, Spain
d Paediatric Allergology and Pulmonology Unit, Department of Paediatrics, University Autonoma of Barcelona, and Corporacio Sanitaria Parc Tauli, Hospital of Sabadell, Barcelona, Spain
e Pediatric Allergy and Immunology Unit, Virgen Arrixaca Clinic Universitary Hospital, Murcia, Spain
f Allergy and Clinical Immunology Section, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain
g Servicio de Alergología. Complejo Hospitalario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Pamplona, Spain
h Publications Office of the European Union, Luxembourg
i Paediatric Allergology and Neumology Unit, Complejo Hospitalario Universitario de Granada, Spain
Ver másRead
4151
Timeswas read the article
480
Total PDF
3671
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 62 | 2 | 64 |
| 2025 11 | 117 | 18 | 135 |
| 2025 10 | 53 | 5 | 58 |
| 2025 9 | 69 | 16 | 85 |
| 2025 8 | 96 | 12 | 108 |
| 2025 7 | 181 | 9 | 190 |
| 2025 6 | 86 | 3 | 89 |
| 2025 5 | 58 | 5 | 63 |
| 2025 4 | 42 | 3 | 45 |
| 2025 3 | 70 | 4 | 74 |
| 2025 2 | 72 | 4 | 76 |
| 2025 1 | 74 | 6 | 80 |
| 2024 12 | 84 | 0 | 84 |
| 2024 11 | 45 | 2 | 47 |
| 2024 10 | 46 | 4 | 50 |
| 2024 9 | 48 | 2 | 50 |
| 2024 8 | 33 | 2 | 35 |
| 2024 7 | 56 | 1 | 57 |
| 2024 6 | 52 | 1 | 53 |
| 2024 5 | 39 | 1 | 40 |
| 2024 4 | 91 | 3 | 94 |
| 2024 3 | 93 | 6 | 99 |
| 2024 2 | 106 | 3 | 109 |
| 2024 1 | 53 | 3 | 56 |
| 2023 12 | 53 | 4 | 57 |
| 2023 11 | 59 | 7 | 66 |
| 2023 10 | 97 | 6 | 103 |
| 2023 9 | 105 | 0 | 105 |
| 2023 8 | 17 | 7 | 24 |
| 2023 7 | 20 | 3 | 23 |
| 2023 6 | 39 | 18 | 57 |
| 2023 5 | 82 | 12 | 94 |
| 2023 4 | 75 | 3 | 78 |
| 2023 3 | 62 | 6 | 68 |
| 2023 2 | 60 | 3 | 63 |
| 2023 1 | 44 | 3 | 47 |
| 2022 12 | 54 | 4 | 58 |
| 2022 11 | 75 | 3 | 78 |
| 2022 10 | 82 | 11 | 93 |
| 2022 9 | 66 | 5 | 71 |
| 2022 8 | 49 | 6 | 55 |
| 2022 7 | 18 | 4 | 22 |
| 2022 6 | 19 | 11 | 30 |
| 2022 5 | 33 | 7 | 40 |
| 2022 4 | 40 | 12 | 52 |
| 2022 3 | 27 | 8 | 35 |
| 2022 2 | 24 | 3 | 27 |
| 2022 1 | 31 | 12 | 43 |
| 2021 12 | 32 | 7 | 39 |
| 2021 11 | 24 | 16 | 40 |
| 2021 10 | 59 | 21 | 80 |
| 2021 9 | 55 | 18 | 73 |
| 2021 8 | 94 | 9 | 103 |
| 2021 7 | 40 | 18 | 58 |
| 2021 6 | 51 | 17 | 68 |
| 2021 5 | 53 | 12 | 65 |
| 2021 4 | 127 | 7 | 134 |
| 2021 3 | 67 | 17 | 84 |
| 2021 2 | 33 | 14 | 47 |
| 2021 1 | 42 | 11 | 53 |
| 2020 12 | 3 | 3 | 6 |
| 2019 1 | 1 | 2 | 3 |
| 2018 7 | 1 | 1 | 2 |
| 2018 6 | 0 | 1 | 1 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 9 | 2 | 11 |
| 2018 1 | 6 | 8 | 14 |
| 2017 12 | 3 | 0 | 3 |
| 2017 11 | 6 | 10 | 16 |
| 2017 9 | 0 | 1 | 1 |
| 2017 8 | 1 | 1 | 2 |
| 2017 6 | 3 | 0 | 3 |
| 2017 5 | 0 | 1 | 1 |
| 2017 3 | 1 | 0 | 1 |
| 2017 2 | 1 | 0 | 1 |
| 2017 1 | 1 | 3 | 4 |
| 2016 11 | 1 | 3 | 4 |
| 2016 10 | 0 | 3 | 3 |
Show all
